John de Groot, M.D.
John de Groot, M.D., is a professor and the chair, ad interim, of Neuro-Oncology at MD Anderson. He joined the faculty in 2004, after completing the Neuro-Oncology Fellowship Program. He is a leading expert in the field of mechanisms of glioblastoma resistance to antiangiogenic therapy. He directs both clinical and translational programs in the fields of glioma angiogenesis and molecularly targeted therapy, which have led to unique therapeutic approaches for the treatment of glioblastoma.
He has served as the principal investigator or co-investigator on multiple funded National Cancer Institute, foundation and industry-sponsored grants. He is the PI of numerous clinical trials involving novel agents being tested in patients with glioblastoma and is a co-leader of MD Anderson’s Glioblastoma Moon Shot™ and Brain Cancer SPORE. He also serves as director of the Neuro-Oncology Fellowship Program and is also helping develop the next generation of neuro-oncologists.
- Kristin Alfaro-Munoz, program manager
- Veerakumar Balasubramaniyan, Ph.D., research scientist
- Sabbir Khan, Ph.D., postdoctoral fellow
- Sandeep Mittal, Ph.D., postdoctoral fellow